Abstract:Terpenoids represent a diverse class of molecules that provide a wealth of opportunities to address many human health and societal issues. The expansive array of structures and functionalities that have been evolved in nature provide an excellent pool of molecules for use in human therapeutics. While this class of molecules has members with therapeutic properties including anticancer, antiparasitic, antimicrobial, antiallergenic, antispasmodic, antihyperglycemic, anti-inflammatory, and immunomodulatory properties, supply limitations prevent the large scale use of some molecules. Many of these molecules are only found in ppm levels in nature thus requiring massive harvesting to obtain sufficient amounts of the drug. Synthetic biology and metabolic engineering provide innovative approaches to increase the production of the desired molecule in the native organism, and most importantly, transfer the biosynthetic pathways to other hosts. Microbial systems are well studied, and genetic manipulations allow the optimization of microbial metabolisms for the production of common terpenoid precursors. Using a host of tools, unprecedented advancements in the large scale production of terpenoids have been achieved in recent years. Identification of limiting steps and pathway regulation, coupled with design strategies to minimize terpenoid byproducts wih a high flux to the desired biosynthetic pathways, have yielded greater than 100-fold improvements in the production of a range of terpenoids. This review focuses on the biodiversity of terpenoids, the biosynthetic pathways involved, and engineering efforts to maximize the production through these pathways.

In Vivo Platforms for Terpenoid Overproduction and the Generation of Chemical Diversity.

Strategies for terpenoid overproduction and new terpenoid discovery.

Releasing the Potential Power of Terpene Synthases by A Robust Precursor Supply Platform

Cytochrome P450s in plant terpenoid biosynthesis: discovery, characterization and metabolic engineering

Heterologous expression and metabolic engineering tools for improving terpenoids production

Toward a photosynthetic microbial platform for terpenoid engineering

Advances in Metabolic Engineering of Saccharomyces Cerevisiae for Terpenoids Biosynthesis

Expanding the structural diversity of terpenes by synthetic biology approaches

Production and engineering of terpenoids in plant cell culture

In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli

Metabolic Perturbation and Synthetic Biology Strategies for Plant Terpenoid Production—An Updated Overview

Advances on the Plant Terpenoid Isoprenoid Biosynthetic Pathway and Its Key Enzymes

Biosynthesis of monoterpenoid and sesquiterpenoid as natural flavors and fragrances

Plant Metabolic Engineering Strategies for the Production of Pharmaceutical Terpenoids.

Metabolic Engineering Strategies for Sustainable Terpenoid Flavor and Fragrance Synthesis

Production of Terpenoids by Synthetic Biology Approaches

Translational fusion of terpene synthases for metabolic engineering: Lessons learned and practical considerations

Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms

Metabolic engineering of microbes for monoterpenoid production

Compartmentalization Engineering of Yeasts to Overcome Precursor Limitations and Cytotoxicity in Terpenoid Production

Terpenoid Metabolic Engineering in Photosynthetic Microorganisms